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Introduction 
 
Tablet is one of the most common pharmaceutical dosage forms, it is able 
to deliver the appropriate amount of the active pharmaceutical ingredient (API) at 
the appropriate site of the gastrointestinal tract with the appropriate release rate. 
Nevertheless, patients suffering from swallowing difficulties may be unable to 
use this type of medicine due to its solid nature. Dysphagia, i.e. swallowing 
difficulties is a common problem among elderly and paediatric patients and many 
illnesses may be associated with this condition. The orally disintegrating tablet 
(ODT), or, alternatively the orodispersible tablet dosage form is specifically 
developed to disintegrate in the mouth in a short period even if there is only a 
low amount of saliva present. Once the tablet has disintegrated in the mouth, the 
resultant suspension is easy to swallow compared to the original structure. 
The administration of an ODT may not result inevitably in faster onset of 
the therapeutic effect, but it has several advantages over conventional tablets, and 
could possess beneficial clinical, medical, technical, and marketing features. 
Usually ODTs are formulated as bioequivalent line extensions of existing 
products; however, it is possible to promote drug absorption through local oromucosal 
tissues, and through pre-gastric, gastric and post-gastric parts of the gastrointestinal 
tract. 
ODT products have several advantages over liquid dosage forms, which 
are useful in the case of swallowing difficulties, but manufacturing of ODTs is 
more difficult process compared to conventional tablets due to their special 
properties. There are several manufacturing methods to produce ODTs, but the 
method has its drawbacks in all cases. Tablets need to have an acceptable taste 
due to the bitter taste most of the drugs and very short disintegration time in the 
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mouth in addition to the pharmacopoeial requirements. Fast disintegration is 
generally achieved by a special tablet structure characterised by loosely 
compacted or lyophilised porous structure, highly swelling excipients, 
effervescent components or other special features. The availability of 
superdisintegrant excipients made the production of various kinds of ODT 
products possible using conventional tableting methods. These unique polymeric 
materials are cross-linked forms of hygroscopic polymers, which are able to 
absorb large amounts of water and swell to a remarkable degree after contact 
with saliva. 
Valuable in vitro characterisation of these products plays also an 
important role during the development of the formulations in addition to the 
technological considerations. 
 
Aims 
 
The purposes of my work were the followings: 
 Water content determination of pharmaceutical superdisintegrants by 
ATR-FTIR spectroscopy, 
 Tablet preparation for the screening of the efficiency of different 
pharmaceutical superdisintegrants, 
 Tablet preparation by exploiting of the swelling of crospovidone and the 
phase transition of xylitol, 
 Development of a method for the in vitro determination of the 
disintegration times of different ODTs, 
 Formation of hydrogen-bonded polymer complexes to sustain the release 
of a water soluble API. 
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Methods 
 
Different superdisintegrant powders were stored at different humidity 
conditions for given periods in small containers to absorb water. Nine samples of 
different water contents from five commercial excipients were prepared for water 
content and FTIR measurements, thus 45 samples were involved in the 
investigation. Initial water content of the superdisintegrants was determined by 
the loss on drying method. The amount of absorbed water was calculated based 
on weight changes of the samples and measured with analytical balance. At the 
end of the conditioning of the superdisintegrants, the weights of the samples were 
measured, then spectral measurements were carried out. ATR-FTIR spectra were 
collected using a Jasco FT/IR-4200 spectrophotometer with an ATR PRO470-H 
single reflection accessory (Jasco). The area under curve values (AUC) of spectra 
between 1510 and 1050 cm
-1 
were called AUCpolymer, since this region was 
characteristic to the degree of the polymer compaction on the ATR accessory and 
the AUC values of spectra between 3700 and 2800 cm
-1
 region were called 
AUCpolymer × water, since this value depended on both the water content and the 
polymer compaction. The ratio of AUCpolymer × water :  AUCpolymer was proportional 
to the amount of the absorbed water per dry polymer weight. Calibration lines 
were calculated based on these ratios and the measured water contents using 
linear regression. 
Tablets were prepared for screening the efficacy of superdisintegrants. 
Directly compressible mannitol was used as filler and the applied 
superdisintegrants were as follows: crospovidone, croscarmellose sodium and 
sodium starch glycolate. Tablets contained the superdisintegrants at three levels, 
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i.e. they contained 3, 5, and 7% w/w superdisintegrant. Two tableting pressures 
were applied to tablet preparation by using different penetration distances of the 
upper punch into the die. The pressure levels were adjusted to obtain 
significantly different tablets in terms of hardness and disintegration for each 
formulation. Wetting times of tablets were measured by placing them on the 
surface of a slice of six-layered paper immersed in 4 ml methylene blue solution 
using a small glass vessel. Wetting was complete, when water was observable on 
the whole surface of the tablets. Consistency of the wetted tablets was measured 
immediately after the complete wetting in the case of tablets. The hardness of the 
wetted tablets was estimated by a manual measurement, i.e. the investigator 
pressed carefully the wetted tablet by finger and rated the consistency of the 
tablet. In vitro disintegration times of tablets were measured by dropping them 
into a glass vessel filled with 20 ml water. Complete disintegration took place 
when no coherent solid portion of the tablet remained. 
Tablets were prepared by exploiting the swelling of crospovidone and the 
phase transition of xylitol. All formulation contained mannitol as filler, milled 
anhydrous citric acid as flavouring agent, xylitol as melting component and 
sodium stearyl fumarate as lubricant. Some formulation contained additional 
fillers. Superdisintegrants were crospovidones, the sodium starch glycolate and 
the croscarmellose sodium. Different formulation series were successively 
prepared and compared. In the case of each series, there were few differences 
between the formulations in order to examine the effects of the components or 
the preparation methods. Each series was treated using the same procedure. The 
prepared tablets were stored over saturated NaCl solution in a desiccator in order 
to absorb water. Tablets were subjected to a temperature of 93 °C for 12 minutes 
in a drying chamber, which caused partial melting of the xylitol component. In 
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vivo disintegration times of the tablets were determined by a healthy volunteer in 
a blind randomized order. Complete disintegration was achieved when there was 
no perceptible solid particle in the mouth.  
Tablets were prepared for the in vitro determination of disintegration 
times of ODTs. Excipients for tablet preparations were spray-dried mannitol as 
filler, sodium stearyl fumarate as lubricant, milled anhydrous citric acid and 
sodium bicarbonate in 1:1 mass ratio as effervescent agent, and milled anhydrous 
citric acid as flavouring agent. Superdisintegrants were crospovidon, 
croscarmellose sodium, and sodium starch glycolate. The first five types of 
tablets (T1-T5, called calibration tablets) were used to determine the optimum 
conditions of the texture analysis method. The other tablets (T6-T9) were used to 
evaluate the optimized method. A CT3 texture analyzer (Brookfield Engineering 
Laboratories) was used for the measurements. Tablets were attached to a 
cylindrical probe head. The device where disintegration took place consisted of a 
miniature stainless steel test sieve which was placed on an extruded polystyrene 
(XPS) plate and the disintegration medium was poured into the space between 
the XPS plate and the sieve with pipette. The volume of the medium was  
sufficient to create a homogenous fluid layer over the surface of the mesh of the 
sieve. After starting the measurement, the tablet was moved towards the surface 
of the disintegration medium. The instrument started to record the load-
displacement points (curves) (100 points/mm) with its software (TexturePro CT, 
Brookfield Engineering Laboratories) as the tablet reached the mesh of the sieve. 
The endpoint (where the probe got into contact with the mesh) was detectable 
based on the shape of the load-displacement curves. In vivo disintegration times 
of the tablets were determined by a healthy volunteer in a blind randomized 
order. Complete disintegration was achieved when there was no perceptible solid 
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particle in the mouth. In the case of each texture analysis measurement the area 
under curve (AUC) values were calculated based on the recorded load–
displacement curves. Lines were laid on short sections (0.1 - 0.2 mm) of each 
recorded curve before and after the endpoints and their angles were calculated in 
order to gain the correction factor called k. The k correction factor was calculated 
from these angles using the Eq. (1): 
 
         (1) 
 
Based on the AUC and k values an empirical function was constructed to predict 
the oral disintegration times: 
 
        (2) 
 
where n1 and n2 are exponents of the AUC values and k correction factor, 
respectively while c was a multiplier calculated from the in vivo disintegration 
times: 
 
        (3) 
 
A c value belongs to each AUC, k, n1, and n2 combination in the case of each 
calibration tablet based on Eq. (3). Under optimum circumstances, these c values 
are nearly identical, and their average (cav) is characteristic to the whole system 
including the tablets, their in vivo disintegration times and the parameters of the 
texture analysis method. The in vitro DT values of the calibration tablets will be 
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close to their in vivo DT values using this averaged c value (cav) in Eq. (3). The in 
vivo DT value of all tablets (T1 - T9) was predicted by Eq. (2) using cav in place 
of the c value after the determination of the optimum circumstances at the 
evaluation procedure. After determination of regression equations for the AUC 
values and the k correction factors for each calibration tablet, it was possible to 
collectively investigate the in vitro DT functions and the c values of the 
calibration tablets using Eqs. (2) and (3) by changing the independent parameters 
of the texture analysis method via a mathematical procedure and to find a 
combination of the independent variables where the c values were similar in the 
case of the five calibration tablets. Using their average (cav) the in vitro DT 
values were calculated and compared with their in vivo DT values with the SSR 
function: 
 
    (4) 
 
where i was the number of the tablet. The resulted sum of squared residuals 
function (SSR) was minimized during the optimization procedure since the closer 
the in vitro and in vivo disintegration times were, the smaller the SSR became. 
All nine types of tablets were measured with the texture analyzer using the 
obtained, optimized settings and the in vitro DT values were compared to their in 
vivo values in order to evaluate the efficiency of the optimization. 
Hydrogen-bonded polymer complexes were prepared to mask the bitter 
taste of desloratadine. Desloratadine salt was dissolved in purified water and the 
pH of the solution was adjusted to 3.6 using 1M HCl solution. Then 
crospovidone was added to the solution and thick, paste-like suspension was 
prepared in a metallic bowl using a pestle. Carbopol
®
 solution was prepared 
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separately with water and their concentrations were set to 0.8% w/w. The 
suspension was drawn into syringe and it was pumped into the intensively stirred 
Carbopol
®
 solution using a syringe pump through a silicone tube. The 
homogenizer was stopped after the addition of the suspension, and the 
precipitated complex was floated on the solution. The precipitate was dried in a 
vacuum chamber (60 °C, 150 mbar, 24 h). The dried pieces were milled and the 
obtained granules were fractionated using a vibratory sieve shaker into the 
following particle size fractions: <90 μm, 90-180 μm, 180-355 μm, 355-500 μm. 
The dissolution tests of the hydrogen-bonded polymer complexes were 
performed in phosphate-citrate buffers according the USP method 2. The 
released drug was determined spectrophotometrically. The pH-dependency of the 
release rate of complexes was measured with dissolution tests performed in 
Erlenmeyer flasks using the 355-500 μm sieve fractions. 
 
Results 
 
 A novel method was developed for fast water content determination of 
superdisintegrants, which is useful as an evaluation tool, as well.  
 The observation of water sorption could be very easily recorded with the 
ATR-FTIR spectra of superdisintegrants (or other similar excipient), and 
the constructed regression lines are able to give information about its 
extent, as well. 
 The comparison of the three most frequently applied superdisintegrants 
helped to gain information about the in vitro behaviour of these 
compounds. Croscarmellose sodium was selected as the most promising 
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excipient in small amounts and after direct compression with mannitol, its 
disintegration was the best in vitro which was also confirmed in vivo. 
 A novel method - preparation of fast disintegrating tablets by phase 
transition of sugar alcohols - was modified and further evaluated. Some of 
the influencing parameters were investigated and it was concluded that the 
adhesion of the melted sugar alcohol component to the filler is critical 
considering the hardness of the tablets. It was also shown, that there is an 
upper limit of the amount of the melting component and the external 
lubrication could be more advantageous for this type of formulation 
considering the disintegration times. 
 Due to the lack of a widespread and useful in vitro disintegration time 
determination process, an optimised method was developed based on 
texture analysis measurements. The method was able to predict the oral 
disintegration times of different tablets prepared by direct compression 
with or without effervescent components with high accuracy. 
 Hydrogen bonded polymer complexes were prepared as a carrier for a 
water soluble model drug, desloratadine hemisulphate in order to mask its 
unpleasant taste. A new method was developed which enabled the mixing 
of the water insoluble crospovidone with the Carbopol
®
 solution, since the 
conventional techniques usually use polymer solutions for the complex 
preparations. The dried and milled complex particles had unique pH-
dependent dissolution characteristics. 
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Conclusion  
The development of orally disintegrating tablets is a complex process, 
where different requirements should be met therefore it is advisable to study all 
aspects of the formulations. Various technologies were evaluated, which can 
facilitate the development of orally disintegrating tablets. It was shown that the 
combinations of different methods in the research phase of the development 
could be useful for the promotion of the further phases of technological 
development. Superdisintegrants, one of the most important components of ODT 
formulations, were characterised in terms of both physico-chemical features and 
efficiency. 
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